Vertex Pharmaceuticals Incorporated (0QZU.L)

USD 454.25

(-3.03%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 22.73 Billion 18.15 Billion 13.43 Billion 11.75 Billion 8.31 Billion 6.24 Billion
Total Current Assets 14.14 Billion 12.68 Billion 9.01 Billion 7.82 Billion 4.6 Billion 3.7 Billion
Cash And Short Term Investments 11.22 Billion 10.77 Billion 7.52 Billion 6.65 Billion 3.8 Billion 3.16 Billion
Cash and Cash Equivalents 10.37 Billion 10.5 Billion 6.79 Billion 5.98 Billion 3.1 Billion 2.65 Billion
Short Term Investments 849.2 Million 274.5 Million 729.9 Million 670.71 Million 698.97 Million 518.1 Million
Net Receivables 1.56 Billion 1.44 Billion 1.13 Billion 885.35 Million 633.51 Million 409.68 Million
Inventory 738.8 Million 460.6 Million 353.1 Million 280.77 Million 167.5 Million 124.36 Million
Other Current Assets 620.5 Million 74.4 Million 187.2 Million 308.35 Million 213.51 Million 74.04 Million
Total Non-Current Assets 8.58 Billion 5.46 Billion 4.41 Billion 3.92 Billion 3.7 Billion 2.54 Billion
Net PPE 1.45 Billion 1.1 Billion 1.09 Billion 958.53 Million 745.08 Million 812 Million
Good Will And Intangible Assets 1.92 Billion 1.69 Billion 1.4 Billion 1.4 Billion 1.4 Billion 50.38 Million
Good Will 1.08 Billion 1.08 Billion 1.4 Billion 1.4 Billion 1.4 Billion 50.38 Million
Intangible Assets 839.9 Million 603.6 Million 400 Million 400 Million 400 Million -
Long-Term Investments 2.59 Billion 99.4 Million 85.8 Million 20.8 Million 44.15 Million -
Tax Assets 1.81 Billion 1.24 Billion 934.5 Million 882.77 Million 1.19 Billion 1.49 Billion
Other Non Current Assets 796.7 Million 1.32 Billion 901.1 Million 662.51 Million 326.94 Million 181.54 Million
Other Assets - - - - - -
Total Liabilities 5.14 Billion 4.23 Billion 3.33 Billion 3.06 Billion 2.23 Billion 1.81 Billion
Total Current Liabilities 3.54 Billion 2.43 Billion 1.87 Billion 1.56 Billion 1.2 Billion 715.48 Million
Account Payables 364.9 Million 303.9 Million 195 Million 155.13 Million 87.61 Million 110.98 Million
Tax Payables 99.5 Million 123.3 Million 211.3 Million 104.17 Million 72.29 Million -
Short Term Debt 83.7 Million 89.4 Million 46.9 Million 42.43 Million 30.29 Million 9.81 Million
Deferred Revenue 170.3 Million 159.6 Million 171.7 Million 191.51 Million 62.33 Million 554.08 Million
Other Current Liabilities 2.92 Billion 1.87 Billion 1.46 Billion 1.17 Billion 1.02 Billion 40.58 Million
Total Non Current Liabilities 1.6 Billion 1.8 Billion 1.45 Billion 1.5 Billion 1.02 Billion 1.09 Billion
Long-Term Debt 724.7 Million 471.6 Million 556.7 Million 581.47 Million 577.37 Million 567.16 Million
Deferred Revenue Non Current -924.1 Million - - - 88.76 Million 82.57 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 877.7 Million 1.33 Billion 902.2 Million 923.4 Million 451.32 Million 528.05 Million
Other Liabilities - - - - - -
Total Equity 17.58 Billion 13.91 Billion 10.1 Billion 8.68 Billion 6.08 Billion 4.43 Billion
Stock Holders Equity 17.58 Billion 13.91 Billion 10.1 Billion 8.68 Billion 6.08 Billion 4.43 Billion
Common Stock 2.6 Million 2.6 Million 2.5 Million 2.59 Million 2.58 Million 2.54 Million
Retained Earnings 10.14 Billion 6.52 Billion 3.2 Billion 858.66 Million -1.85 Billion -2.98 Billion
Accumulated other comprehensive income -14.3 Million 800 Thousand 15.9 Million -68.48 Million -1.97 Million 659 Thousand
Common Stock Equity 17.58 Billion 13.91 Billion 10.1 Billion 8.68 Billion 6.08 Billion 4.43 Billion
Capital Lease Obligation 724.7 Million 471.6 Million 556.7 Million 581.47 Million 577.37 Million 567.16 Million
Total Investments 3.44 Billion 274.5 Million 729.9 Million 670.71 Million 698.97 Million 518.1 Million
Total Debt 808.4 Million 561 Million 556.7 Million 581.47 Million 577.37 Million 567.16 Million
Net Debt -9.56 Billion -9.94 Billion -6.23 Billion -5.4 Billion -2.53 Billion -2.08 Billion

Balance Sheet Charts